Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in Oklahoma

The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Physician-discretion program
✗ No
LEGAL
3 oz on person; 8 oz at…
POSSESSION
$100/yr
STATE FEE
7–21 d
TIMELINE
Physician-discretion program. The state does not list this condition by name, but its statute or regulator permits a certifying physician to add conditions case-by-case. Patients should expect to bring full diagnostic records to the certification visit.

Oklahoma statute and program

The Oklahoma Medical Marijuana Program is the operating authority for Oklahoma patient certification. The authoritative legal text is: Title 63 OK Stat. §§ 420 et seq.: Oklahoma Medical Marijuana Authority Act.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in Oklahoma

The Oklahoma Medical Marijuana Program requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. Get a written recommendation from any Oklahoma-licensed physician. Under State Question 788 (codified at 63 O.S. §420 et seq.), any Oklahoma-licensed MD or DO may issue a written recommendation for medical cannabis. The Oklahoma program is the broadest practitioner-discretion model in the United States — there is no enumerated qualifying-condition list. The physician determines that medical cannabis is appropriate for the patient using "the same accepted standards a reasonable and prudent physician would follow."
  2. Apply through the OMMA online portal. The patient creates an account on the Oklahoma Medical Marijuana Authority (OMMA) online portal, uploads the physician recommendation, a current Oklahoma driver license or state ID, a passport-style photo, and proof of Oklahoma residency. Two-year licenses are now standard since 2023 OMMA rule revisions.
  3. Pay the $100 state fee (or $20 for SoonerCare/Medicaid). The two-year Oklahoma medical marijuana patient license fee is $100, reduced to $20 for patients enrolled in SoonerCare (Oklahoma Medicaid) or Medicare. Caregivers register separately and pass a state background check. Fees are paid online during the OMMA application submission.
  4. Receive the license and purchase from any OMMA-licensed dispensary. OMMA patient licenses are typically issued within 14 days of complete application; expedited processing is available. Oklahoma allows possession of 3 ounces on the person, 8 ounces at home, 1 ounce of concentrate, 72 ounces of edibles, and 6 mature plus 6 seedling plants. Oklahoma honors out-of-state medical cards under its 30-day temporary license program ($100 application fee) and has the highest per-capita patient enrollment of any US state.
State registration fee
$100
Physician visit (typical)
$50–$150
Certification to card
7–21 days
Out-of-state patients
Eligible
Minors
Eligible with caregiver

For full Oklahoma registration steps, fees, and reciprocity rules, see the Oklahoma cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the Oklahoma medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Oklahoma list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

Not by name, but Oklahoma permits physician discretion. Under Oklahoma Medical Marijuana Program, a certifying physician can add a condition like Lupus (Systemic Lupus Erythematosus) on a case-by-case basis when the physician judges that the patient would benefit from medical cannabis. This is different from a state where the qualifying-condition list is fixed in statute. Whether a particular physician will certify Lupus (Systemic Lupus Erythematosus) depends on the physician's training, the strength of the patient's documentation, and the practitioner's reading of the available evidence — evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). Patients should expect to bring full diagnostic records to the certification visit.

How do I get a Oklahoma medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Step one is finding a physician licensed in Oklahoma who is registered with Oklahoma Medical Marijuana Program and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Oklahoma honors out-of-state medical cards under its reciprocity rules — uncommon, and worth verifying before relying on it. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Title 63 OK Stat. §§ 420 et seq.: Oklahoma Medical Marijuana Authority Actaccessed May 16, 2026
  2. Oklahoma Medical Marijuana Authorityaccessed May 16, 2026
  3. Wikipedia: Cannabis in Oklahomaaccessed May 16, 2026
  4. OMMA: Patient Application Fees and Processaccessed May 18, 2026
  5. OMMA: Out-of-State (Temporary) Patient Licenseaccessed May 18, 2026
  6. Oklahoma Legislature bill trackeraccessed May 18, 2026
  7. NORML: Oklahoma Laws & Penaltiesaccessed May 18, 2026
  8. National Academies of Sciences, Engineering, and Medicine (2017): The Health Effects of Cannabis and Cannabinoidsaccessed May 18, 2026
  9. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  10. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  11. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  12. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026